Abstract :
[en] In this short piece, I critically discuss the development of harm to innovation as a theory of anticompetitive harm in EU merger policy, following the conditional approval of the Dow/Dupont in 2017. © 2018 Institute of Competition Law.
Scopus citations®
without self-citations
0